Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination
Bo Sun, Hui-Hsin Chang, Ari Salinger, Beverly Tomita, Mandar Bawadekar, Caitlyn L. Holmes, Miriam A. Shelef, Eranthie Weerapana, Paul R. Thompson, I-Cheng Ho
Bo Sun, Hui-Hsin Chang, Ari Salinger, Beverly Tomita, Mandar Bawadekar, Caitlyn L. Holmes, Miriam A. Shelef, Eranthie Weerapana, Paul R. Thompson, I-Cheng Ho
View: Text | PDF
Research Article Immunology

Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination

  • Text
  • PDF
Abstract

Dysregulated citrullination, a unique form of posttranslational modification catalyzed by the peptidylarginine deiminases (PADs), has been observed in several human diseases, including rheumatoid arthritis. However, the physiological roles of PADs in the immune system are still poorly understood. Here, we report that global inhibition of citrullination enhances the differentiation of type 2 helper T (Th2) cells but attenuates the differentiation of Th17 cells, thereby increasing the susceptibility to allergic airway inflammation. This effect on Th cells is due to inhibition of PAD2 but not PAD4. Mechanistically, PAD2 directly citrullinates GATA3 and RORγt, 2 key transcription factors determining the fate of differentiating Th cells. Citrullination of R330 of GATA3 weakens its DNA binding ability, whereas citrullination of 4 arginine residues of RORγt strengthens its DNA binding. Finally, PAD2-deficient mice also display altered Th2/Th17 immune response and heightened sensitivity to allergic airway inflammation. Thus, our data highlight the potential and caveat of PAD2 as a therapeutic target of Th cell–mediated diseases.

Authors

Bo Sun, Hui-Hsin Chang, Ari Salinger, Beverly Tomita, Mandar Bawadekar, Caitlyn L. Holmes, Miriam A. Shelef, Eranthie Weerapana, Paul R. Thompson, I-Cheng Ho

×

Figure 2

Recapitulating the effects of Cl-am by inhibiting PAD2 but not PAD4.

Options: View larger image (or click on image) Download as PowerPoint
Recapitulating the effects of Cl-am by inhibiting PAD2 but not PAD4.
(A)...
(A) The transcript levels of indicated PADs in Th cells (n = 3) and macrophages (n = 2) of C57BL/6 mice were measured with real-time PCR and normalized against the levels of actin. (B) The levels of PAD2 proteins in indicated C57BL/6 Th cells and PAD2-KO Th2 cells were examined with Western blotting using indicated antibodies. (C) At indicated time points during the differentiation of WT Th2 and Th17 cells, the level of PAD2 protein was examined with Western blotting. A parallel gel was probed with anti-tubulin for loading control. (D and E) WT Th cells were stimulated with anti-CD3, anti-CD28, and/or IL-2 in the absence (D) or presence (E) of cyclosporine A (CsA) or sotrastaurin (Sot) for 2 days. The level of PAD2 proteins was examined with Western blotting. Representative Western blots from 2 experiments are shown in B–D. (F) C57BL/6 effector Th cells were generated in the presence of AFM30a (left panel) or GSK199 (right panel) at indicated concentrations. The expression of indicated cytokines by the Th cells after restimulation with anti-CD3 is shown (n = 3–4, 1-way ANOVA). (G–J) Th cells obtained from WT DBA/1J (G–J, n = 3–4), PAD2-KO (G, I, and J, n = 3–5), or PAD4-KO (H, n = 2) mice were differentiated into Th1, Th2, and Th17 cells for 5 days. The production of indicated cytokines after restimulation with anti-CD3 was measured with ELISA or real-time PCR (G and H, 2-tailed Student’s t test for G). Data from the same experiments are connected with lines in H. Whole cell extract from WT DBA/1J or PAD2-KO Th cells were examined with Western blotting using anti-citH3 (I). A parallel gel was probed with anti-H3 for loading controls. The normalized density of cit-H3 of indicated cells is shown in the dot blot of I. The transcript levels of PADs in restimulated WT DBA/1J, and PAD2-KO Th2 cells were quantified with real-time PCR and shown in J (n = 3–4).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts